Advantages of α-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients

Peter S. Johnston, Harold E. Lebovitz, Robert F. Coniff, Donald C. Simonson, Philip Raskin, Catherine L. Munera

Research output: Contribution to journalArticlepeer-review

137 Scopus citations

Fingerprint

Dive into the research topics of 'Advantages of α-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds